PubMed Health⌕ Search

PubMed · 7568914

Urine storage mechanisms.

Abstract

The urine storage process depends upon the coordinated control of a storage chamber, the bladder body, and its outlets, the bladder base and urethra. While urine storage disorders are of considerable clinical significance, the mechanisms underlying this process are poorly understood. Many species possess an ability to alter the duration of urine storage in the face of widely varying filling rates. The storage chamber appears largely responsible for this ability to alter capacity and compliance. However, there has been some controversy over the contribution of intrinsic smooth muscle and extrinsic neural systems to the storage process, which is partly related to the various methodologies used in experimental and clinical studies. Thus, the storage phase is greatly influenced by the filling regimes, anaesthesia, non-specific factors and infusates used in these studies. Further, the techniques used to examine and measure urine storage mechanisms often obscure the subtle nature of this process. There is little doubt that, under natural filling conditions, myogenic factors allow the bladder to store increasing volumes at low pressure. More recent studies indicate that, in addition to a quiescent parasympatho-excitatory drive, the extrinsic neural systems contribute to the storage phase with a precisely controlled sympatho-inhibitory drive. However, the sympatho-inhibitory drive does not increase capacity by promoting high compliance. Instead this drive partially reduces the level of bladder wall tension transduced by the bladder wall mechanoreceptors, and thus delays the time at which the micturition tension threshold is reached.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C W Vaughan, P M Satchell. 1995. Urine storage mechanisms.. https://pubmed.ncbi.nlm.nih.gov/7568914/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗